This page shows the latest Cedila Therapeutics news and features for those working in and with pharma, biotech and healthcare.
1 trial of its lead candidate ARV-110 in prostate cancer earlier this year, ahead of rival biotechs such as C4 Therapeutics and Kymera Therapeutics as well as big pharma firms ... Other approaches are also in early-stage testing. Deubiquitylating (DUB)
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...